Last update 28 Jun 2025

RG-4929

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
R-4929, R4929, RG 4929
+ [3]
Target
Action
inhibitors
Mechanism
11β-HSD1 inhibitors(Corticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors)
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glaucoma, Open-AnglePhase 2
United States
01 Dec 2011
Glaucoma, Open-AnglePhase 2
Bulgaria
01 Dec 2011
Glaucoma, Open-AnglePhase 2
Czechia
01 Dec 2011
Glaucoma, Open-AnglePhase 2
Hungary
01 Dec 2011
Diabetes Mellitus, Type 2Phase 2
United States
01 Apr 2009
Diabetes Mellitus, Type 2Phase 2
Austria
01 Apr 2009
Diabetes Mellitus, Type 2Phase 2
Germany
01 Apr 2009
Metabolic dysfunction-associated steatotic liver diseasePhase 1
Austria
01 Apr 2011
Metabolic dysfunction-associated steatotic liver diseasePhase 1
Germany
01 Apr 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
35
fhffgihtao(oiqhygqogh) = There was no statistically significant difference in change of IOP from baseline. cnljehiuzr (uqoiuqhyqp )
Negative
29 Jun 2017
Placebo
Not Applicable
-
Placebo
owengixnrp(uidlgsodel) = mild increases in VLDL cholesterol with RO838 were not significant nisgzsvgzs (fjfgcvkbij )
Negative
25 Sep 2013
RO151 200mg BID
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free